Benitec Biopharma Inc. shares its Q3 results, reflecting its position in the pharmaceutical preparations sector amidst competition.
| Name | Benitec Biopharma Inc. |
|---|---|
| CIK | 0001808898 |
| Tickers | BNTC |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (510) 780-0819 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Benitec Biopharma Inc. shares its Q3 results, reflecting its position in the pharmaceutical preparations sector amidst competition.
Benitec Biopharma Inc. reports Q3 results and changes its fiscal year-end to December 31, enhancing its operational alignment with industry standards.
Benitec Biopharma Inc. shares positive interim results for BB-301, indicating progress in its clinical trials and potential industry impact.
Benitec Biopharma Inc. files a preliminary proxy statement for its annual stockholder meeting, outlining key proposals for governance and operational oversight.
Benitec Biopharma Inc. has filed a definitive proxy statement detailing proposals for its upcoming shareholder meeting, impacting governance and executive compensation.
Benitec Biopharma Inc. shares updates following FDA feedback from a Type C meeting, impacting future strategies in the pharmaceutical industry.
336 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | 10-Q | 10-Q | 0001193125-26-459383 | 001-39267 | 261549136 | 34 | 6900758 | 1 | 1 | |
| 2026-11-13 | 8-K | 8-K | 2.02,5.03,9.01 | 0001193125-26-459339 | 001-39267 | 261549076 | 34 | 378706 | 1 | 1 |
| 2026-10-28 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-435159 | 001-39267 | 261492495 | 34 | 214436 | 1 | 1 |
| 2026-10-20 | DEFA14A | DEFA14A | 0001193125-26-426741 | 001-39267 | 261473032 | 34 | 6454216 | |||
| 2026-10-20 | DEF 14A | DEF 14A | 0001193125-26-426733 | 001-39267 | 261473003 | 34 | 11331752 | 1 | 1 | |
| 2026-10-05 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-413177 | 001-39267 | 261438829 | 34 | 192008 | 1 | 1 |
| 2026-09-30 | 8-K | 8-K | 4.01 | 0001193125-26-409052 | 001-39267 | 261427241 | 34 | 141986 | 1 | 1 |
| 2026-09-24 | 8-K | 8-K | 4.01,9.01 | 0001193125-26-401110 | 001-39267 | 261405170 | 34 | 163042 | 1 | 1 |
| 2026-09-21 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003021 | 333-298927 | 261395155 | 33 | 1696 | ||
| 2026-09-14 | S-3 | S-3 | 0001193125-26-390758 | 333-298927 | 261378220 | 33 | 793192 | 1 | 1 | |
| 2026-09-14 | 10-K | 10-K | 0001193125-26-390570 | 001-39267 | 261377424 | 34 | 11391958 | 1 | 1 | |
| 2026-09-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-390539 | 001-39267 | 261377340 | 34 | 405719 | 1 | 1 |
| 2026-06-30 | 4 | 4 | 0001193125-26-290586 | 4645 | ||||||
| 2026-05-29 | 8-K | 8-K | 5.02 | 0001193125-26-248289 | 001-39267 | 261044480 | 34 | 145746 | 1 | 1 |
| 2026-05-28 | 4 | 4 | 0001193125-26-245918 | 6144 | ||||||
| 2026-05-28 | 3 | 3 | 0001193125-26-245915 | 2966 | ||||||
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-222885 | 001-39267 | 26975953 | 34 | 7500799 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-222879 | 001-39267 | 26975948 | 34 | 458191 | 1 | 1 |
| 2026-04-03 | UPLOAD | filename1.pdf | 0000000000-26-003380 | 001-39267 | 39477 | |||||
| 2026-03-20 | CORRESP | filename1.htm | 0001193125-26-117627 | 18780 | ||||||
| 2026-03-20 | 10-K/A | 10-K/A | 0001193125-26-117604 | 001-39267 | 26778192 | 34 | 11449047 | 1 | 1 | |
| 2026-02-24 | UPLOAD | filename1.pdf | 0000000000-26-001911 | 001-39267 | 42129 | |||||
| 2026-02-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-047742 | 001-39267 | 26623511 | 34 | 798128 | 1 | 1 |
| 2026-02-12 | 10-Q | 10-Q | 0001193125-26-047737 | 001-39267 | 26623508 | 34 | 7507148 | 1 | 1 | |
| 2026-02-11 | 424B3 | 424B3 | 0001193125-26-044984 | 333-293077 | 26617447 | 33 | 166628 | |||
| 2026-02-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000516 | 333-293077 | 26618206 | 33 | 1695 | ||
| 2026-02-06 | CORRESP | filename1.htm | 0001193125-26-041308 | 6165 | ||||||
| 2026-02-06 | UPLOAD | filename1.pdf | 0000000000-26-001290 | 333-293077 | 40001 | |||||
| 2026-01-30 | S-3 | S-3 | 0001193125-26-031753 | 333-293077 | 26583290 | 33 | 365064 | 1 | 1 | |
| 2026-01-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000038777-26-000024 | 005-91726 | 26576018 | 34 | 21732 | |||
| 2026-01-26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000082 | 5081 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4.xml | 0000899140-25-001479 | 37577 | ||||||
| 2025-12-22 | 4 | xslF345X05/form4.xml | 0000899140-25-001459 | 38621 | ||||||
| 2025-12-08 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000332 | 005-91726 | 251555151 | 34 | 11036 | |||
| 2025-12-03 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000066 | 005-91726 | 251546758 | 34 | 18637 | |||
| 2025-12-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000851 | 5079 | ||||||
| 2025-12-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000850 | 5885 | ||||||
| 2025-12-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000849 | 5088 | ||||||
| 2025-12-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000848 | 5096 | ||||||
| 2025-12-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000847 | 5045 | ||||||
| 2025-12-02 | 8-K | 8-K | 5.07 | 0001193125-25-305475 | 001-39267 | 251544247 | 34 | 168685 | 1 | 1 |
| 2025-11-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000813 | 5109 | ||||||
| 2025-11-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000812 | 5160 | ||||||
| 2025-11-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000811 | 5154 | ||||||
| 2025-11-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-283351 | 001-39267 | 251488395 | 34 | 218746 | 1 | 1 |
| 2025-11-14 | 10-Q | 10-Q | 0001193125-25-283274 | 001-39267 | 251488027 | 34 | 6880608 | 1 | 1 | |
| 2025-11-12 | DEFA14A | DEFA14A | 0001193125-25-275653 | 001-39267 | 251468255 | 34 | 15342 | |||
| 2025-11-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000899140-25-001257 | 005-91726 | 251468123 | 34 | 104948 | |||
| 2025-11-10 | 4 | xslF345X05/form4.xml | 0000899140-25-001256 | 27679 | ||||||
| 2025-11-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000718 | 5108 | ||||||
| 2025-11-07 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000717 | 2858 | ||||||
| 2025-11-07 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-270490 | 001-39267 | 251460195 | 34 | 712714 | 1 | 1 |
| 2025-11-07 | 424B5 | 424B5 | 0001193125-25-270487 | 333-290455 | 251460186 | 33 | 606221 | |||
| 2025-11-05 | 424B5 | 424B5 | 0001193125-25-267262 | 333-290455 | 251455159 | 33 | 651511 | |||
| 2025-11-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000038777-25-000219 | 005-91726 | 251447324 | 34 | 22419 | |||
| 2025-11-03 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001193125-25-261665 | 001-39267 | 251442096 | 34 | 17423141 | 1 | 1 |
| 2025-10-14 | DEFA14A | DEFA14A | 0001193125-25-239136 | 001-39267 | 251392483 | 34 | 471177 | |||
| 2025-10-14 | DEF 14A | DEF 14A | 0001193125-25-239131 | 001-39267 | 251392471 | 34 | 1270362 | 1 | 1 | |
| 2025-09-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003153 | 333-290455 | 251358030 | 33 | 1696 | ||
| 2025-09-26 | CORRESP | filename1.htm | 0001193125-25-220122 | 20595 | ||||||
| 2025-09-25 | UPLOAD | filename1.pdf | 0000000000-25-010472 | 333-290455 | 39951 | |||||
| 2025-09-22 | S-3 | S-3 | 0001193125-25-211549 | 333-290455 | 251330894 | 33 | 839961 | 1 | 1 | |
| 2025-09-22 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-211462 | 001-39267 | 251330661 | 34 | 420572 | 1 | 1 |
| 2025-09-22 | 10-K | 10-K | 0001193125-25-211361 | 001-39267 | 251330349 | 34 | 14101774 | 1 | 1 | |
| 2025-09-12 | 8-K | 8-K | 4.02 | 0000950170-25-114530 | 001-39267 | 251311628 | 34 | 153787 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000251 | 005-91726 | 251216350 | 34 | 10561 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000247 | 005-91726 | 251216012 | 34 | 10564 | |||
| 2025-07-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-157095 | 001-39267 | 251113777 | 34 | 152496 | 1 | 1 |
| 2025-06-02 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001810 | 333-287566 | 251017063 | 33 | 1696 | ||
| 2025-06-02 | 424B3 | 424B3 | 0001193125-25-133423 | 333-287566 | 251015981 | 33 | 205581 | |||
| 2025-05-29 | CORRESP | filename1.htm | 0001193125-25-130616 | 6348 | ||||||
| 2025-05-29 | UPLOAD | filename1.pdf | 0000000000-25-005638 | 333-287566 | 39987 | |||||
| 2025-05-23 | S-3 | S-3 | 0001193125-25-125878 | 333-287566 | 25982944 | 33 | 253465 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-049523 | 005-91726 | 25954425 | 34 | 10899 | |||
| 2025-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000173 | 005-91726 | 25944058 | 34 | 10494 | |||
| 2025-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-119402 | 001-39267 | 25942695 | 34 | 233923 | 1 | 1 |
| 2025-05-14 | 10-Q | 10-Q | 0001193125-25-119383 | 001-39267 | 25942617 | 34 | 8476094 | 1 | 1 | |
| 2025-05-09 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000038777-25-000082 | 005-91726 | 25929386 | 34 | 22418 | |||
| 2025-04-02 | 4 | xslF345X05/form4.xml | 0000899140-25-000486 | 34350 | ||||||
| 2025-03-28 | 8-K | 8-K | 8.01 | 0001193125-25-067232 | 001-39267 | 25787683 | 34 | 141562 | 1 | 1 |
| 2025-03-28 | 4 | xslF345X05/form4.xml | 0000899140-25-000479 | 27767 | ||||||
| 2025-03-28 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000899140-25-000478 | 005-91726 | 25787238 | 34 | 15874 | |||
| 2025-03-27 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-065613 | 001-39267 | 25780424 | 34 | 234717 | 1 | 1 |
| 2025-03-26 | 424B5 | 424B5 | 0001193125-25-063610 | 333-282957 | 25770698 | 33 | 529335 | |||
| 2025-03-26 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-063235 | 001-39267 | 25770250 | 34 | 719414 | 1 | 1 |
| 2025-03-20 | 8-K | 8-K | 8.01 | 0001193125-25-059398 | 001-39267 | 25757829 | 34 | 172652 | 1 | 1 |
| 2025-03-19 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-057153 | 001-39267 | 25750858 | 34 | 189786 | 1 | 1 |
| 2025-03-13 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-005393 | 6031 | ||||||
| 2025-03-03 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-004077 | 6289 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000094 | 005-91726 | 25625799 | 34 | 10574 | |||
| 2025-02-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-026659 | 001-39267 | 25623413 | 34 | 246021 | 1 | 1 |
| 2025-02-14 | 10-Q | FORM 10-Q | 0001193125-25-026631 | 001-39267 | 25623261 | 34 | 8306244 | 1 | 1 | |
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-012950 | 005-91726 | 25620464 | 34 | 7842 | |||
| 2025-01-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000038777-25-000005 | 005-91726 | 25556929 | 34 | 26568 | |||
| 2025-01-03 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-000257 | 14030 | ||||||
| 2024-12-31 | 8-K/A | 8-K/A | 5.02 | 0001193125-24-287065 | 001-39267 | 241591149 | 34 | 146952 | 1 | 1 |
| 2024-12-26 | 4 | xslF345X05/form4.xml | 0000899140-24-001385 | 34054 | ||||||
| 2024-12-13 | 8-K | 8-K | 5.02 | 0001193125-24-278529 | 001-39267 | 241548575 | 34 | 145200 | 1 | 1 |
| 2024-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020503 | 5892 | ||||||
| 2024-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020470 | 5068 | ||||||
| 2024-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020468 | 5052 | ||||||
| 2024-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020466 | 5095 | ||||||
| 2024-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020464 | 5135 | ||||||
| 2024-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-020462 | 5121 | ||||||
| 2024-12-10 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-24-274395 | 001-39267 | 241539243 | 34 | 160007 | 1 | 1 |
| 2024-12-06 | 8-K | 8-K | 5.07 | 0001193125-24-272533 | 001-39267 | 241533062 | 34 | 152198 | 1 | 1 |
| 2024-12-06 | SC 13G/A | Benitec112924.txt | 0001274173-24-000279 | 005-91726 | 241531744 | 34 | 13524 | |||
| 2024-12-05 | 4 | xslF345X05/form4.xml | 0000899140-24-001318 | 27563 | ||||||
| 2024-11-21 | 4 | xslF345X05/form4.xml | 0000899140-24-001299 | 33650 | ||||||
| 2024-11-18 | SC 13D/A | SCHEDULE 13D/A, AMENDMENT #2 | 0000899140-24-001285 | 005-91726 | 241471977 | 34 | 79699 | |||
| 2024-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-24-119174 | 005-91726 | 241463810 | 34 | 10695 | |||
| 2024-11-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-258694 | 001-39267 | 241463464 | 34 | 243976 | 1 | 1 |
| 2024-11-14 | DEFA14A | DEFA14A | 0001193125-24-258690 | 001-39267 | 241463418 | 34 | 24878 | |||
| 2024-11-14 | 10-Q | FORM 10-Q | 0001193125-24-258672 | 001-39267 | 241463234 | 34 | 6747238 | 1 | 1 | |
| 2024-11-14 | 8-K | 8-K | 5.02 | 0001193125-24-258668 | 001-39267 | 241463179 | 34 | 140268 | 1 | 1 |
| 2024-11-14 | SC 13G/A | JANUS AMENDMENT | 0001274173-24-000117 | 005-91726 | 241459997 | 34 | 12971 | |||
| 2024-11-13 | SC 13G/A | SC 13G/A | 0001104659-24-117720 | 005-91726 | 241454557 | 34 | 53439 | |||
| 2024-11-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-11-12 16:30:00 | 9999999995-24-003464 | 333-282957 | 241450894 | 33 | 1703 | ||
| 2024-11-12 | CORRESP | filename1.htm | 0001193125-24-255599 | 6229 | ||||||
| 2024-11-08 | UPLOAD | filename1.pdf | 0000000000-24-012497 | 333-282957 | 39987 | |||||
| 2024-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000038777-24-000179 | 005-91726 | 241434261 | 34 | 26683 | |||
| 2024-11-06 | SC 13G/A | JANUS OWNS OVER 10 | 0001274173-24-000083 | 005-91726 | 241430602 | 34 | 13349 | |||
| 2024-11-01 | S-3 | S-3 | 0001193125-24-249919 | 333-282957 | 241419905 | 33 | 704937 | |||
| 2024-10-25 | SC 13G/A | JANUS OWNS OVER 10 | 0001274173-24-000082 | 005-91726 | 241396310 | 34 | 10979 | |||
| 2024-10-22 | DEF 14A | DEF 14A | 0001193125-24-241155 | 001-39267 | 241387936 | 34 | 551184 | |||
| 2024-10-22 | DEFA14A | DEFA14A | 0001193125-24-241156 | 001-39267 | 241387148 | 34 | 605021 | |||
| 2024-10-15 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-237227 | 001-39267 | 241369386 | 34 | 176190 | 1 | 1 |
| 2024-10-15 | 424B5 | 424B5 | 0001193125-24-237145 | 333-277310 | 241369001 | 33 | 379106 | |||
| 2024-10-11 | 424B5 | 424B5 | 0001193125-24-236800 | 333-277310 | 241368214 | 33 | 368423 | |||
| 2024-10-11 | PRE 14A | PRE 14A | 0001193125-24-236694 | 001-39267 | 241368065 | 34 | 550836 | |||
| 2024-10-11 | 8-K | 8-K | 1.01,9.01 | 0001193125-24-236782 | 001-39267 | 241368053 | 34 | 449830 | 1 | 1 |
| 2024-10-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-234458 | 001-39267 | 241360776 | 34 | 165281 | 1 | 1 |
| 2024-10-01 | S-8 | S-8 | 0001193125-24-230255 | 333-282451 | 241344003 | 33 | 69733 | |||
| 2024-09-30 | SC 13D/A | SCHEDULE 13D/A, AMENDMENT #1 | 0000899140-24-001043 | 005-91726 | 241340452 | 34 | 100654 | |||
| 2024-09-30 | 4 | xslF345X05/form4.xml | 0000899140-24-001042 | 48209 | ||||||
| 2024-09-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-226999 | 001-39267 | 241329511 | 34 | 250083 | 1 | 1 |
| 2024-09-26 | 10-K | 10-K | 0001193125-24-226968 | 001-39267 | 241329407 | 34 | 11201672 | 1 | 1 | |
| 2024-09-05 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-24-213348 | 001-39267 | 241279369 | 34 | 152522 | 1 | 1 |
| 2024-07-29 | DEF 14A | DEF 14A | 0001193125-24-187599 | 001-39267 | 241152797 | 34 | 964165 | |||
| 2024-07-19 | PRE 14A | PRE 14A | 0001193125-24-181702 | 001-39267 | 241128356 | 34 | 1030462 | |||
| 2024-07-15 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-179108 | 001-39267 | 241118051 | 34 | 375853 | 1 | 1 |
| 2024-07-08 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-013470 | 2856 | ||||||
| 2024-07-01 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-173338 | 001-39267 | 241091062 | 34 | 177996 | 1 | 1 |
| 2024-05-29 | 424B3 | 424B3 | 0001193125-24-149218 | 333-279439 | 24998871 | 33 | 258461 | |||
| 2024-05-28 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-05-28 16:00:00 | 9999999995-24-001662 | 333-279439 | 24993878 | 33 | 1702 | ||
| 2024-05-23 | CORRESP | filename1.htm | 0001193125-24-146220 | 6342 | ||||||
| 2024-05-22 | UPLOAD | filename1.pdf | 0000000000-24-005951 | 333-279439 | 40204 | |||||
| 2024-05-16 | S-1 | S-1 | 0001193125-24-139625 | 333-279439 | 24953198 | 33 | 375753 | |||
| 2024-05-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-136730 | 001-39267 | 24936962 | 34 | 333871 | 1 | 1 |
| 2024-05-13 | 10-Q | FORM 10-Q | 0001193125-24-136727 | 001-39267 | 24936945 | 34 | 5706950 | 1 | 1 | |
| 2024-05-02 | 3 | xslF345X02/form3.xml | 0000899140-24-000517 | 38830 | ||||||
| 2024-04-29 | SC 13D | SCHEDULE 13D | 0000899140-24-000506 | 005-91726 | 24890688 | 34 | 127352 | |||
| 2024-04-29 | SC 13G | SC 13G | 0001140361-24-022952 | 005-91726 | 24890569 | 34 | 55606 | |||
| 2024-04-29 | SC 13G | SC 13G | 0001104659-24-053660 | 005-91726 | 24888238 | 34 | 64394 | |||
| 2024-04-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001012975-24-000183 | 021-511623 | 24876402 | 33 | 10935 | ||
| 2024-04-19 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-24-101289 | 001-39267 | 24855465 | 34 | 755741 | 1 | 1 |
| 2024-04-18 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-100080 | 001-39267 | 24852978 | 34 | 27714202 | 1 | 1 |
| 2024-04-11 | SC 13G/A | BENITEC BIOPHARMA INC. | 0000902664-24-002844 | 005-91726 | 24837680 | 34 | 99240 | |||
| 2024-03-08 | 8-K | 8-K | 5.02 | 0001193125-24-063667 | 001-39267 | 24734588 | 34 | 141577 | 1 | 1 |
| 2024-03-08 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-005970 | 5145 | ||||||
| 2024-03-08 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-005969 | 5134 | ||||||
| 2024-03-05 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-03-05 16:00:00 | 9999999995-24-000607 | 333-277310 | 24724276 | 33 | 1702 | ||
| 2024-03-01 | CORRESP | filename1.htm | 0001193125-24-055978 | 6034 | ||||||
| 2024-02-28 | UPLOAD | filename1.pdf | 0000000000-24-002254 | 333-277310 | 40230 | |||||
| 2024-02-26 | DEL AM | DEL AM | 0001193125-24-045491 | 333-277310 | 24673791 | 33 | 7042 | |||
| 2024-02-23 | S-3 | S-3 | 0001193125-24-044499 | 333-277310 | 24671217 | 33 | 683371 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024117 | 005-91726 | 24641172 | 34 | 137863 | |||
| 2024-02-13 | SC 13G/A | JHG PLC & JHBIF >5% | 0001274173-24-000053 | 005-91726 | 24633401 | 34 | 13452 | |||
| 2024-02-13 | SC 13G/A | d10964649_13g-a.htm | 0000919574-24-001070 | 005-91726 | 24629857 | 34 | 146448 | |||
| 2024-02-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-032956 | 001-39267 | 24622681 | 34 | 252519 | 1 | 1 |
| 2024-02-13 | 10-Q | FORM 10-Q | 0001193125-24-032940 | 001-39267 | 24622654 | 34 | 4980956 | 1 | 1 | |
| 2023-12-26 | S-8 | S-8 | 0001193125-23-302272 | 333-276267 | 231511162 | 33 | 68962 | |||
| 2023-12-11 | SC 13G/A | beni23a2.htm | 0000038777-23-000172 | 005-91726 | 231477378 | 34 | 228980 | |||
| 2023-12-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022120 | 5101 | ||||||
| 2023-12-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022119 | 5074 | ||||||
| 2023-12-07 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-022118 | 5058 | ||||||
| 2023-12-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-290709 | 001-39267 | 231472567 | 34 | 155141 | 1 | 1 |
| 2023-11-30 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-285671 | 001-39267 | 231453972 | 34 | 161334 | 1 | 1 |
| 2023-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-275384 | 001-39267 | 231395255 | 34 | 235871 | 1 | 1 |
| 2023-11-13 | 10-Q | FORM 10-Q | 0001193125-23-275377 | 001-39267 | 231395233 | 34 | 6551567 | 1 | 1 | |
| 2023-10-20 | DEFA14A | DEFA14A | 0001193125-23-259962 | 001-39267 | 231337448 | 34 | 482399 | |||
| 2023-10-20 | DEF 14A | DEF 14A | 0001193125-23-259531 | 001-39267 | 231335904 | 34 | 1278206 | 1 | 1 | |
| 2023-10-16 | 8-K | 8-K | 5.02 | 0001193125-23-257001 | 001-39267 | 231328066 | 34 | 140250 | 1 | 1 |
| 2023-09-28 | 8-K | 8-K | 8.01 | 0001193125-23-245807 | 001-39267 | 231290902 | 34 | 144300 | 1 | 1 |
| 2023-09-21 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-239127 | 001-39267 | 231267780 | 34 | 238864 | 1 | 1 |
| 2023-09-21 | 10-K | 10-K | 0001193125-23-239121 | 001-39267 | 231267770 | 34 | 9526449 | 1 | 1 | |
| 2023-09-18 | 8-K | 8-K | 5.02 | 0001193125-23-237014 | 001-39267 | 231261930 | 34 | 139366 | 1 | 1 |
| 2023-09-11 | SC 13G/A | beni23a1.htm | 0000038777-23-000133 | 005-91726 | 231247140 | 34 | 228507 | |||
| 2023-08-25 | SC 13G | BENITEC BIOPHARMA INC. | 0000902664-23-004626 | 005-91726 | 231208746 | 34 | 101357 | |||
| 2023-08-21 | SC 13G | SC 13G | 0001104659-23-093916 | 005-91726 | 231189199 | 34 | 136345 | |||
| 2023-08-18 | SC 13G | JHG PLC OWNS 9.9% OF BENITEC | 0001274173-23-000086 | 005-91726 | 231185727 | 34 | 13369 | |||
| 2023-08-18 | SC 13G/A | SC 13G/A | 0001104659-23-093323 | 005-91726 | 231184290 | 34 | 49730 | |||
| 2023-08-14 | 4 | FORM 4 SUBMISSION | 0000899243-23-018119 | 8019 | ||||||
| 2023-08-14 | 4 | 4 | 0000950170-23-042536 | 6837 | ||||||
| 2023-08-11 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-210679 | 001-39267 | 231163867 | 34 | 777850 | 1 | 1 |
| 2023-08-10 | 8-K | 8-K | 3.01 | 0001193125-23-209112 | 001-39267 | 231160238 | 34 | 140356 | 1 | 1 |
| 2023-08-10 | 424B4 | 424B4 | 0001193125-23-209029 | 333-273177 | 231159306 | 33 | 2329744 | |||
| 2023-08-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-08-08 17:30:00 | 9999999995-23-002308 | 333-273177 | 231153186 | 33 | 1654 | ||
| 2023-08-07 | S-1/A | S-1/A | 0001193125-23-204498 | 333-273177 | 231145726 | 33 | 2596560 | |||
| 2023-08-03 | CORRESP | filename1.htm | 0001193125-23-202432 | 6600 | ||||||
| 2023-08-03 | CORRESP | filename1.htm | 0001193125-23-202427 | 5776 | ||||||
| 2023-08-03 | S-1/A | S-1/A | 0001193125-23-202324 | 333-273177 | 231138229 | 33 | 2849175 | |||
| 2023-07-31 | S-1/A | S-1/A | 0001193125-23-198629 | 333-273177 | 231125158 | 33 | 2662216 | |||
| 2023-07-25 | 8-K | 8-K | 3.03,5.03,7.01,8.01,9.01 | 0001193125-23-193295 | 001-39267 | 231108003 | 34 | 186112 | 1 | 1 |
| 2023-07-11 | UPLOAD | filename1.pdf | 0000000000-23-007358 | 40091 | ||||||
| 2023-07-07 | S-1 | S-1 | 0001193125-23-183854 | 333-273177 | 231077450 | 33 | 2324190 | |||
| 2023-06-26 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-174479 | 001-39267 | 231039458 | 34 | 159035 | 1 | 1 |
| 2023-06-15 | 8-K | 8-K | 5.02 | 0001193125-23-167929 | 001-39267 | 231017610 | 34 | 139998 | 1 | 1 |
| 2023-06-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-013639 | 5053 | ||||||
| 2023-06-15 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-013634 | 5064 | ||||||
| 2023-05-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-144217 | 001-39267 | 23918531 | 34 | 254447 | 1 | 1 |
| 2023-05-15 | 10-Q | FORM 10-Q | 0001193125-23-144211 | 001-39267 | 23918501 | 34 | 5230916 | 1 | 1 | |
| 2023-04-18 | SC 13G/A | d10623048_13g-a.htm | 0000919574-23-002619 | 005-91726 | 23827032 | 34 | 116646 | |||
| 2023-03-08 | 8-K | 8-K | 3.01 | 0001193125-23-064582 | 001-39267 | 23716560 | 34 | 141982 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021115 | 005-91726 | 23624728 | 34 | 64014 | |||
| 2023-02-13 | SC 13G/A | d9927314_13g-a.htm | 0000919574-23-001024 | 005-91726 | 23616137 | 34 | 126059 | |||
| 2023-02-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-034348 | 001-39267 | 23614805 | 34 | 252176 | 1 | 1 |
| 2023-02-13 | 10-Q | 10-Q | 0001193125-23-034339 | 001-39267 | 23614797 | 34 | 4247767 | 1 | 1 | |
| 2023-02-08 | SC 13G/A | SCHEDULE 13G/A BNTC SILVERARC | 0001816307-23-000004 | 005-91726 | 23596277 | 34 | 66319 | |||
| 2023-01-23 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-012670 | 001-39267 | 23542566 | 34 | 162369 | 1 | 1 |
| 2022-12-19 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-12-19 16:15:00 | 9999999995-22-003586 | 333-268763 | 221472768 | 33 | 1654 | ||
| 2022-12-15 | CORRESP | filename1.htm | 0001193125-22-305870 | 5863 | ||||||
| 2022-12-14 | UPLOAD | filename1.pdf | 0000000000-22-013474 | 40097 | ||||||
| 2022-12-13 | S-1 | S-1 | 0001193125-22-303006 | 333-268763 | 221458290 | 33 | 2132204 | |||
| 2022-12-12 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-22-302288 | 001-39267 | 221456168 | 34 | 155656 | 1 | 1 |
| 2022-12-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-023660 | 5069 | ||||||
| 2022-12-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-023659 | 5026 | ||||||
| 2022-12-09 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-023658 | 5042 | ||||||
| 2022-12-08 | 8-K | 8-K | 5.07,9.01 | 0001193125-22-301044 | 001-39267 | 221452732 | 34 | 159886 | 1 | 1 |
| 2022-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-281980 | 001-39267 | 221375035 | 34 | 239879 | 1 | 1 |
| 2022-11-10 | 10-Q | 10-Q | 0001193125-22-281978 | 001-39267 | 221375029 | 34 | 4118024 | 1 | 1 | |
| 2022-10-25 | DEFA14A | DEFA14A | 0001193125-22-268388 | 001-39267 | 221329704 | 34 | 1240327 | |||
| 2022-10-25 | DEF 14A | DEF 14A | 0001193125-22-268377 | 001-39267 | 221329666 | 34 | 557097 | |||
| 2022-10-18 | 8-K | 8-K | 5.02 | 0001193125-22-264446 | 001-39267 | 221316063 | 34 | 141087 | 1 | 1 |
| 2022-10-14 | PRE 14A | PRE 14A | 0001193125-22-262970 | 001-39267 | 221311589 | 34 | 559244 | |||
| 2022-10-11 | SC 13G | beni22in.htm | 0000038777-22-000166 | 005-91726 | 221303214 | 34 | 227258 | |||
| 2022-10-07 | SC 13G/A | SC 13G/A | 0001104659-22-107022 | 005-91726 | 221300029 | 34 | 50244 | |||
| 2022-09-23 | SC 13G | SC 13G | 0001104659-22-102534 | 005-91726 | 221260955 | 34 | 88968 | |||
| 2022-09-16 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-246077 | 001-39267 | 221247037 | 34 | 785559 | 1 | 1 |
| 2022-09-14 | 424B4 | 424B4 | 0001193125-22-244827 | 333-266417 | 221243640 | 33 | 2284025 | |||
| 2022-09-12 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-09-12 17:30:00 | 9999999995-22-002665 | 333-266417 | 221239660 | 33 | 1654 | ||
| 2022-09-12 | S-1/A | S-1/A | 0001193125-22-242886 | 333-266417 | 221238781 | 33 | 2380519 | |||
| 2022-09-09 | S-1/A | S-1/A | 0001193125-22-241222 | 333-266417 | 221234897 | 33 | 2480733 | |||
| 2022-09-08 | CORRESP | filename1.htm | 0001193125-22-241233 | 6255 | ||||||
| 2022-09-08 | CORRESP | filename1.htm | 0001193125-22-241227 | 6735 | ||||||
| 2022-09-07 | 8-K | 8-K | 3.01 | 0001193125-22-240014 | 001-39267 | 221231367 | 34 | 141286 | 1 | 1 |
| 2022-09-02 | 10-K | 10-K | 0001193125-22-237075 | 001-39267 | 221223259 | 34 | 6921867 | 1 | 1 | |
| 2022-09-02 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-237060 | 001-39267 | 221223254 | 34 | 239876 | 1 | 1 |
| 2022-08-11 | CORRESP | filename1.htm | 0001193125-22-218076 | 6985 | ||||||
| 2022-08-10 | S-1/A | S-1/A | 0001193125-22-217292 | 333-266417 | 221151643 | 33 | 155489 | |||
| 2022-08-08 | CORRESP | filename1.htm | 0001193125-22-214694 | 6873 | ||||||
| 2022-08-08 | CORRESP | filename1.htm | 0001193125-22-214461 | 5518 | ||||||
| 2022-08-08 | S-1/A | S-1/A | 0001193125-22-214263 | 333-266417 | 221142736 | 33 | 2789447 | |||
| 2022-08-04 | UPLOAD | filename1.pdf | 0000000000-22-008266 | 40104 | ||||||
| 2022-07-29 | S-1 | S-1 | 0001193125-22-206703 | 333-266417 | 221121350 | 33 | 2419924 | |||
| 2022-05-16 | 10-Q | FORM 10-Q | 0001193125-22-150924 | 001-39267 | 22925598 | 34 | 5474407 | 1 | 1 | |
| 2022-05-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-150922 | 001-39267 | 22925581 | 34 | 251621 | 1 | 1 |
| 2022-02-14 | 10-Q | FORM 10-Q | 0001193125-22-039683 | 001-39267 | 22625496 | 34 | 4795999 | 1 | 1 | |
| 2022-02-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-039653 | 001-39267 | 22625445 | 34 | 241900 | 1 | 1 |
| 2022-02-09 | SC 13G | schedule13gbntcsilverarc.htm | 0001816307-22-000007 | 005-91726 | 22611396 | 34 | 67961 | |||
| 2022-02-09 | SC 13G | schedule13gbntcsilverarc.htm | 0001816307-22-000005 | 005-91726 | 22611389 | 34 | 67961 | |||
| 2022-02-09 | SC 13G | schedule13gbntcsilverarc.htm | 0001816307-22-000006 | 005-91726 | 22607792 | 34 | 67961 | |||
| 2022-02-08 | SC 13G/A | BNTC 13G/A | 0001393825-22-000194 | 005-91726 | 22602062 | 34 | 54457 | |||
| 2022-01-21 | 8-K/A | 8-K/A | 5.07 | 0001193125-22-014852 | 001-39267 | 22546305 | 34 | 146736 | 1 | 1 |
| 2022-01-13 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-22-001861 | 005-91726 | 22528211 | 34 | 45964 | |||
| 2021-12-23 | S-8 | S-8 | 0001193125-21-366283 | 333-261874 | 211517556 | 33 | 51485 | |||
| 2021-12-21 | 8-K | 8-K | 3.03,5.03,9.01 | 0001193125-21-363633 | 001-39267 | 211509820 | 34 | 156853 | 1 | 1 |
| 2021-12-13 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-21-355561 | 001-39267 | 211488879 | 34 | 170456 | 1 | 1 |
| 2021-12-10 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-012696 | 5024 | ||||||
| 2021-12-10 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-012695 | 5067 | ||||||
| 2021-12-10 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-21-012694 | 5040 | ||||||
| 2021-12-09 | 4 | FORM 4 | 0001104659-21-148207 | 12803 | ||||||
| 2021-12-09 | 3 | FORM 3 | 0001104659-21-148204 | 3600 | ||||||
| 2021-11-15 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-21-329092 | 001-39267 | 211406741 | 34 | 220307 | 1 | 1 |
| 2021-11-15 | 10-Q | FORM 10-Q | 0001193125-21-328795 | 001-39267 | 211406074 | 34 | 3951587 | 1 | 1 | |
| 2021-10-22 | DEF 14A | DEF 14A | 0001193125-21-304643 | 001-39267 | 211338666 | 34 | 1360543 | |||
| 2021-10-12 | PRE 14A | PRE 14A | 0001193125-21-296224 | 001-39267 | 211316704 | 34 | 1355765 | |||
| 2021-09-20 | 8-K | 8-K | 5.02 | 0001193125-21-276778 | 001-39267 | 211262090 | 34 | 17393 | ||
| 2021-09-20 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-276763 | 001-39267 | 211262079 | 34 | 87074 | ||
| 2021-09-20 | 10-K | 10-K | 0001193125-21-276758 | 001-39267 | 211262074 | 34 | 10952917 | 1 | 1 | |
| 2021-05-12 | 10-Q | 10-Q | 0001193125-21-159276 | 001-39267 | 21916124 | 34 | 3828703 | 1 | ||
| 2021-05-07 | SC 13G | d8849683.htm | 0000919574-21-003288 | 005-91726 | 21903570 | 34 | 118167 | |||
| 2021-04-29 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-21-140764 | 001-39267 | 21871854 | 34 | 217601 | ||
| 2021-04-29 | 424B5 | 424B5 | 0001193125-21-140732 | 333-253259 | 21871731 | 33 | 1851716 | |||
| 2021-04-28 | SC 13G | SC 13G | 0001104659-21-056654 | 005-91726 | 21865629 | 34 | 163530 | |||
| 2021-04-28 | FWP | FWP | 0001193125-21-135023 | 333-253259 | 21861129 | 34 | 11989 | |||
| 2021-04-27 | FWP | FWP | 0001193125-21-134509 | 333-253259 | 21860180 | 34 | 11921 | |||
| 2021-04-27 | 424B5 | 424B5 | 0001193125-21-134352 | 333-253259 | 21859549 | 33 | 1854325 | |||
| 2021-04-14 | SC 13G/A | SC 13G/A | 0001104659-21-050294 | 005-91726 | 21826446 | 34 | 57457 | |||
| 2021-04-12 | SC 13G/A | MS AMENDMENT | 0000895421-21-000321 | 005-91726 | 21821262 | 34 | 17600 | |||
| 2021-04-05 | SC 13G | SC 13G | 0001104659-21-046246 | 005-91726 | 21803635 | 34 | 55031 | |||
| 2021-03-22 | SC 13G | MS INITIAL | 0000895421-21-000297 | 005-91726 | 21761759 | 34 | 17250 | |||
| 2021-02-26 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-02-26 16:00:00 | 9999999995-21-000768 | 333-253259 | 21693489 | 33 | 1653 | ||
| 2021-02-25 | CORRESP | filename1.htm | 0001193125-21-056606 | 5595 | ||||||
| 2021-02-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-054896 | 001-39267 | 21675007 | 34 | 6897129 | ||
| 2021-02-24 | UPLOAD | filename1.pdf | 0000000000-21-002219 | 40087 | ||||||
| 2021-02-18 | S-3 | S-3 | 0001193125-21-047700 | 333-253259 | 21649476 | 33 | 587821 | |||
| 2021-02-18 | S-8 | S-8 | 0001193125-21-047697 | 333-253258 | 21649462 | 33 | 86359 | |||
| 2021-02-12 | SC 13G/A | form13ga.htm | 0001493152-21-003634 | 005-91726 | 21627161 | 34 | 163781 | |||
| 2021-02-09 | 10-Q | 10-Q | 0001193125-21-033243 | 001-39267 | 21603880 | 34 | 3692963 | 1 | ||
| 2021-02-09 | SC 13G | BNTC 13G | 0001393825-21-000015 | 005-91726 | 21602845 | 34 | 59145 | |||
| 2021-01-19 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-21-002807 | 005-91726 | 21535265 | 34 | 60197 | |||
| 2021-01-08 | SC 13G/A | SABBY 13G-A BNTC 1.08.21 | 0001535610-21-000071 | 005-91726 | 21516075 | 34 | 14861 | |||
| 2020-12-15 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-318182 | 001-39267 | 201390188 | 34 | 94393 | ||
| 2020-12-14 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-20-317105 | 001-39267 | 201387083 | 34 | 129312 | ||
| 2020-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-20-006261 | 5060 | ||||||
| 2020-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-20-006259 | 5076 | ||||||
| 2020-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-20-006257 | 5103 | ||||||
| 2020-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-20-006255 | 5064 | ||||||
| 2020-12-11 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-20-006253 | 5075 | ||||||
| 2020-11-13 | 10-Q | 10-Q | 0001193125-20-292209 | 001-39267 | 201309103 | 34 | 3054312 | 1 | ||
| 2020-11-03 | 8-K | 8-K | 4.01,9.01 | 0001193125-20-284828 | 001-39267 | 201284229 | 34 | 23595 | ||
| 2020-10-27 | 8-K | 8-K | 5.02 | 0001193125-20-278391 | 001-39267 | 201264189 | 34 | 17531 | ||
| 2020-10-22 | DEF 14A | DEF 14A | 0001193125-20-274452 | 001-39267 | 201255290 | 34 | 1329188 | |||
| 2020-10-13 | SC 13G | SCHEDULE 13G | 0001213900-20-030943 | 005-91726 | 201234465 | 34 | 33544 | |||
| 2020-10-07 | SC 13G | form13g.htm | 0001493152-20-019063 | 005-91726 | 201228040 | 34 | 190314 | |||
| 2020-10-06 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-20-264805 | 001-39267 | 201227223 | 34 | 44999 | ||
| 2020-10-06 | 424B4 | 424B4 | 0001193125-20-264192 | 333-246314 | 201225253 | 33 | 1023690 | |||
| 2020-10-02 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-10-02 09:00:00 | 9999999995-20-002724 | 333-246314 | 201222181 | 33 | 1688 | ||
| 2020-10-01 | CORRESP | filename1.htm | 0001193125-20-260854 | 10297 | ||||||
| 2020-10-01 | CORRESP | filename1.htm | 0001193125-20-260851 | 5890 | ||||||
| 2020-10-01 | S-1/A | S-1/A | 0001193125-20-260736 | 333-246314 | 201214675 | 33 | 1376679 | |||
| 2020-09-23 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-252398 | 001-39267 | 201192630 | 34 | 81186 | ||
| 2020-09-23 | 10-K | FORM 10-K | 0001193125-20-252381 | 001-39267 | 201192525 | 34 | 7434516 | 1 | ||
| 2020-08-24 | UPLOAD | filename1.pdf | 0000000000-20-007885 | 40188 | ||||||
| 2020-08-19 | 8-K/A | 8-K/A | 4.01,9.01 | 0001193125-20-224708 | 001-39267 | 201117249 | 34 | 25310 | ||
| 2020-08-18 | 8-K | 8-K | 8.01 | 0001193125-20-222612 | 001-39267 | 201111287 | 34 | 17246 | ||
| 2020-08-14 | S-1 | FORM S-1 | 0001193125-20-220358 | 333-246314 | 201105160 | 33 | 3996382 | |||
| 2020-06-05 | 8-K | 8-K | 4.01,9.01 | 0001193125-20-162330 | 001-39267 | 20947406 | 34 | 26580 | ||
| 2020-04-27 | 3 | FORM 3 SUBMISSION | 0000899243-20-011340 | 7339 | ||||||
| 2020-04-27 | 3 | FORM 3 SUBMISSION | 0000899243-20-011330 | 5996 | ||||||
| 2020-04-27 | 3 | FORM 3 SUBMISSION | 0000899243-20-011328 | 7125 | ||||||
| 2020-04-27 | 3 | FORM 3 SUBMISSION | 0000899243-20-011325 | 3477 | ||||||
| 2020-04-27 | 3 | FORM 3 SUBMISSION | 0000899243-20-011324 | 6388 | ||||||
| 2020-04-27 | 3 | FORM 3 SUBMISSION | 0000899243-20-011323 | 7051 | ||||||
| 2020-04-15 | 8-K12B | 8-K12B | 3.01,3.02,3.03,5.01,5.02,5.03,5.05,8.01,9.01 | 0001564590-20-016820 | 001-39267 | 20792758 | 34 | 825830 |
One latest value per concept from companyfacts (193 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 36.12M | 2026-11-09 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| dei | EntityListingParValuePerShare | Entity Listing, Par Value Per Share | USD/shares | 0 | 2019-07-01 | 2020-06-30 | 2020 | FY | 10-K | 2020-09-23 | 0001193125-20-252381 |
| dei | EntityPublicFloat | Entity Public Float | USD | 143.06M | 2025-12-31 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 5.52M | 2025-07-01 | 2026-06-30 | DEF 14A | 2026-10-20 | 0001193125-26-426733 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 4.94M | 2025-07-01 | 2026-06-30 | DEF 14A | 2026-10-20 | 0001193125-26-426733 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 9.54M | 2025-07-01 | 2026-06-30 | DEF 14A | 2026-10-20 | 0001193125-26-426733 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 6.52M | 2025-07-01 | 2026-06-30 | DEF 14A | 2026-10-20 | 0001193125-26-426733 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 330.18 | 2025-07-01 | 2026-06-30 | DEF 14A | 2026-10-20 | 0001193125-26-426733 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 27,620 | 2026-09-10 | S-3 | 2026-09-14 | 0001193125-26-390758 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 27,620 | 2026-09-10 | S-3 | 2026-09-14 | 0001193125-26-390758 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 200.00M | 2026-09-10 | S-3 | 2026-09-14 | 0001193125-26-390758 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-09-10 | S-3 | 2026-09-14 | 0001193125-26-390758 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-09-10 | S-3 | 2026-09-14 | 0001193125-26-390758 | |||
| us-gaap | AccountsAndOtherReceivablesNetCurrent | Accounts and Other Receivables, Net, Current | USD | 0 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 7.96M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 1.02M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 112,000 | 2021-09-30 | 2022 | Q1 | 10-Q | 2021-11-15 | 0001193125-21-328795 | |
| us-gaap | AccruedBonusesCurrentAndNoncurrent | Accrued Bonuses | USD | 26,000 | 2023-09-30 | 2024 | Q1 | 10-Q | 2023-11-13 | 0001193125-23-275377 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 0 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 1.33M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -947,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 457.24M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.51M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 6.27M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 5.51M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 11.98M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | Assets | Assets | USD | 179.10M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 178.10M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperation | Disposal Group, Including Discontinued Operation, Assets | USD | 200,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | Cash | Cash | USD | 98.60M | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 176.37M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 2.19M | 2020-07-01 | 2021-03-31 | 2021 | Q3 | 10-Q | 2021-05-12 | 0001193125-21-159276 |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 9.47M | 2020-07-01 | 2021-06-30 | 2021 | FY | 10-K | 2021-09-20 | 0001193125-21-276758 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 176.48M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -3.60M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 11.22 | 2022-09-15 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 2.58M | 2024-04-22 | 2025 | FY | 10-K/A | 2026-03-20 | 0001193125-26-117604 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 19.55M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 35.76M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 160.00M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 34.89M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 34.89M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 4,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -12.91M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | ContractWithCustomerAssetNetCurrent | Contract with Customer, Asset, after Allowance for Credit Loss, Current | USD | 0 | 2020-06-30 | 2020 | FY | 10-K | 2020-09-23 | 0001193125-20-252381 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 681,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsCapitalLossCarryforwards | Deferred Tax Assets, Capital Loss Carryforwards | USD | 250,000 | 2019-06-30 | 2020 | FY | 10-K | 2020-09-23 | 0001193125-20-252381 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 192,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 30.82M | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 254,000 | 2021-06-30 | 2021 | FY | 10-K | 2021-09-20 | 0001193125-21-276758 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 23.50M | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 129,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 5,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 1.30M | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 30.14M | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 146,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 329,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains | Deferred Tax Liabilities, Unrealized Currency Transaction Gains | USD | 206,000 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 | |
| us-gaap | DepositAssets | Deposit Assets | USD | 55,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | Depreciation | Depreciation | USD | 19,000 | 2023-07-01 | 2023-09-30 | 2024 | Q1 | 10-Q | 2023-11-13 | 0001193125-23-275377 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 17,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | DueFromBanks | Due from Banks | USD | 176.37M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.26 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.61 | 2021-07-01 | 2022-03-31 | 2022 | Q3 | 10-Q | 2022-05-16 | 0001193125-22-150924 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.26 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.112 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationDeductionsOther | Effective Income Tax Rate Reconciliation, Deduction, Other, Percent | pure | 0.086 | 2024-07-01 | 2025-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.001 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.157 | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2020-09-23 | 0001193125-20-252381 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.014 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.005 | 2024-07-01 | 2025-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.069 | 2018-07-01 | 2019-06-30 | 2020 | FY | 10-K | 2020-09-23 | 0001193125-20-252381 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -95,000 | 2021-07-01 | 2022-03-31 | 2022 | Q3 | 10-Q | 2022-05-16 | 0001193125-22-150924 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 19,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 608,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 20.50M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 34,000 | 2022-07-01 | 2023-03-31 | 2024 | FY | 10-K | 2024-09-26 | 0001193125-24-226968 |
| us-gaap | ForeignCurrencyExchangeRateTranslation1 | Foreign Currency Exchange Rate, Translation | pure | 0.007 | 2025-06-30 | 2025 | FY | 10-K/A | 2026-03-20 | 0001193125-26-117604 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -23,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -1,000 | 2019-07-01 | 2020-06-30 | 2021 | FY | 10-K | 2021-09-20 | 0001193125-21-276758 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 5.86M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | GrantsReceivableCurrent | Grants Receivable, Current | USD | 636,000 | 2019-06-30 | 2020 | FY | 10-K | 2020-09-23 | 0001193125-20-252381 | |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -45.34M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | -211,000 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 5.10M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | -52,000 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -9.56M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 50,000 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 638,000 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | IncreaseDecreaseInAccountsAndOtherReceivables | Increase (Decrease) in Accounts and Other Receivables | USD | -5,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | IncreaseDecreaseInEmployeeRelatedLiabilities | Increase (Decrease) in Employee Related Liabilities | USD | 56,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -388,000 | 2022-07-01 | 2022-12-31 | 2023 | Q2 | 10-Q | 2023-02-13 | 0001193125-23-034339 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 173,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 1.58M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.06 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 666,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 16,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 518,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 132,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 62,000 | 2023-03-31 | 2023 | Q3 | 10-Q | 2023-05-15 | 0001193125-23-144211 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 291,000 | 2024-03-31 | 2024 | Q3 | 10-Q | 2024-05-13 | 0001193125-24-136727 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 267,000 | 2025-03-31 | 2025 | Q3 | 10-Q | 2025-05-14 | 0001193125-25-119383 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 24,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | Liabilities | Liabilities | USD | 9.45M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 179.10M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 9.08M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 0 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 0 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -3.62M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -12.93M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -45.55M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 1.55M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 14.48M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -14.48M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 100,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 642,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 507,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 135,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 120,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 585,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 108,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 156.00M | 2020-07-01 | 2021-03-31 | 2021 | Q3 | 10-Q | 2021-05-12 | 0001193125-21-159276 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 179,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OtherAssets | Other Assets | USD | 1.87M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 1.62M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 244,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | 16,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 16,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -1,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 21,000 | 2020-12-31 | 2021 | Q2 | 10-Q | 2021-02-09 | 0001193125-21-033243 | |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 6.27M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 105,000 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 1.62M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 244,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 1.16M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 27.90M | 2023-08-11 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 104.50M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 67,000 | 2024-07-01 | 2025-06-30 | 2025 | FY | 10-K/A | 2026-03-20 | 0001193125-26-117604 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 1,000 | 2019-07-01 | 2020-06-30 | 2021 | FY | 10-K | 2021-09-20 | 0001193125-21-276758 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 1.44M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 110,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 0 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 8.62M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 176.48M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 114,000 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -286.65M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 0 | 2024-07-01 | 2024-12-31 | 2024 | Q2 | 10-Q | 2025-02-14 | 0001193125-25-026631 |
| us-gaap | RevenueNotFromContractWithCustomerOther | Revenue Not from Contract with Customer, Other | USD | 5,000 | 2019-07-01 | 2020-06-30 | 2021 | FY | 10-K | 2021-09-20 | 0001193125-21-276758 |
| us-gaap | Revenues | Revenues | USD | 0 | 2025-07-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2022-07-01 | 2023-06-30 | 2023 | FY | 10-K | 2023-09-21 | 0001193125-23-239121 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 5.75M | 2024-04-22 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 4.8 | 2024-04-22 | 2026 | Q3 | 10-Q | 2026-05-14 | 0001193125-26-222885 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 15,000 | 2022-03-31 | 2022 | Q3 | 10-Q | 2022-05-16 | 0001193125-22-150924 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 5.51M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.142 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.274 | 2020-07-01 | 2021-06-30 | 2022 | FY | 10-K | 2022-09-02 | 0001193125-22-237075 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 1.156 | 2022-07-01 | 2023-06-30 | 2023 | FY | 10-K | 2023-09-21 | 0001193125-23-239121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.038 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.006 | 2020-07-01 | 2021-06-30 | 2022 | FY | 10-K | 2022-09-02 | 0001193125-22-237075 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.04 | 2022-07-01 | 2023-06-30 | 2023 | FY | 10-K | 2023-09-21 | 0001193125-23-239121 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 12.07 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | USD | 0 | 2022-06-30 | 2022 | FY | 10-K | 2022-09-02 | 0001193125-22-237075 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 169.65M | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 | |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 625,000 | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 34,000 | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | TimeDepositsAtCarryingValue | Time Deposits, at Carrying Value | USD | 4.57M | 2020-06-30 | 2021 | FY | 10-K | 2021-09-20 | 0001193125-21-276758 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 0 | 2024-07-01 | 2025-06-30 | 2025 | FY | 10-K/A | 2026-03-20 | 0001193125-26-117604 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2022-06-30 | 2022 | FY | 10-K | 2022-09-02 | 0001193125-22-237075 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2023-06-30 | 2023 | FY | 10-K | 2023-09-21 | 0001193125-23-239121 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 5.10M | 2025-07-01 | 2026-06-30 | 2026 | FY | 10-K | 2026-09-14 | 0001193125-26-390570 |
| us-gaap | WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount | WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount | USD | 0 | 2024-07-01 | 2025-06-30 | 2025 | FY | 10-K/A | 2026-03-20 | 0001193125-26-117604 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 49.49M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 8.17M | 2021-07-01 | 2022-03-31 | 2022 | Q3 | 10-Q | 2022-05-16 | 0001193125-22-150924 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 49.49M | 2026-07-01 | 2026-09-30 | 2027 | Q1 | 10-Q | 2026-11-13 | 0001193125-26-459383 |